exp:news_feed:department site="neurology" category_id="291" parse="inward" year="" month="" count="5"

News

Jonathan R. Jagid, M.D.

Laser Therapy Shows Promise for Patients with Refractory Epilepsy

Hope for some people with epileptic seizures not controlled by medication comes in the form of a new minimally invasive technique called laser interstitial thermal therapy. And the University of Miami Health System’s Epilepsy Center is the only facility offering this treatment option in South Florida.

Read more »

From left, Hilit F. Mechaber, M.D., Nanette Vega, M.A., Ivette Motola, M.D., M.P.H., and Stephen Symes, M.D.

Honoring Women in Academic Medicine and Their Achievements

Women in Academic Medicine, the Office of Diversity and Inclusion, and the Committee of Interns and Residents at the University of Miami Miller School of Medicine hosted the annual Evening of Fellowship on January 23, honoring recent successes and achievements of the Miller School’s women faculty. The event began with networking among attendees from various departments, including many chairs and center directors.

Read more »

Dileep R. Yavagal, M.D.

Stroke Stent-Retriever Device Saves Patient with Blocked Coronary Artery

When a heart attack patient with a clot blocking his left main artery arrived at Jackson Memorial Hospital, Cesar E. Mendoza, M.D., attempted unsuccessfully to restore blood flow using conventional balloon angioplasty. He remembered colleague Dileep R. Yavagal, M.D., reporting success capturing and removing the clots of stroke patients using a stent-retriever device and asked him to attempt the same technique on his patient.

Read more »

A Sylvester Comprehensive Cancer Center scientist searches for a cure.

Sylvester and Miller School Awarded $5.7 Million for Cancer and Tobacco-Related Disease Research

The Florida Department of Health has announced the award of 16 grants totaling more than $16 million from the Bankhead-Coley Cancer Research Program and the James and Esther King Biomedical Research Program. Six investigators at Sylvester Comprehensive Cancer Center and the University of Miami Miller School of Medicine were recipients of Bankhead-Coley and King grants totaling $5,728,856.

Read more »

Michael Benatar, M.D., Ph.D.

UM and Orphazyme Announce Successful Phase II Trial of Arimoclomol in ALS Patients

Arimoclomol, a heat shock protein-based therapy, shows promise for the treatment of amyotrophic lateral sclerosis, or ALS, based on the results of a phase II trial initiated and led by Michael Benatar, M.D., Ph.D., professor of neurology at the University of Miami Miller School of Medicine. The study showed the drug is safe and well tolerated, with preliminary evidence of efficacy.

Read more »